arthralgia incidence in trials is generally similar to placebo Rapid weight loss from GLP-1 treatment may alter biomechanical loading on joints, causing temporary adjustment-related discomfort Patients prescribed GLP-1 medications often have type 2 diabetes or obesity, conditions independently associated with increased osteoarthritis rates Seek medical advice for severe, worsening, or persistent joint pain, or if accompanied by swelling, redness, warmth, or systemic symptoms Report suspected medication side effects through the MHRA Yellow Card scheme to support ongoing safety monitoring Table of Contents Understanding GLP-1 Medications and Their Common Side Effects GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), most commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea
Some medications utilized in medically managed weight loss and wellness programs are considered to be used off label and may not be FDA approved for weight loss or health improvement purposes.
Bn nn canh thi im ung theo nhng hng dn sau: Ung khi bng rng: Trc n sng 30 60 pht hoc sau n ti 2 ting hn ch cnh tranh hp thu vi thc n
Ozempic is a brand-name medication containing semaglutide, which belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1)
